NCT01013389View on ClinicalTrials.gov

Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) With Interbody Fusion

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Degenerative Disc Disease
Interventions
PROCEDURE

Actifuse ABX

bone substitute used for posterolateral instrumented lumbar fusion with interbody fusion

PROCEDURE

INFUSE, plus master granules (MGG)

bone substitute in posterolateral instrumented lumbar fusion with interbody fusion

Trial Locations (2)

NSW 2500

Moloney & Associates, Wollongong

8011 JW

Isala Klinik, Zwolle

All Listed Sponsors
collaborator

Apatech, Inc.

INDUSTRY

lead

Baxter Healthcare Corporation

INDUSTRY

NCT01013389 - Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) With Interbody Fusion | Biotech Hunter | Biotech Hunter